Skip to main content
Premium Trial:

Request an Annual Quote

MGI Tech, Nalagenetics Partner for Pharmacogenomics in Singapore, Indonesia

This article has been updated from a previous version to reflect clarifications made by MGI Tech about the nature of the partnership.

NEW YORK – BGI Group affiliate MGI Tech announced on Tuesday that it struck a partnership with Nalagenetics to codevelop a low-coverage whole-genome sequencing (WGS) workflow for risk prediction and pharmacogenomics by optimizing next-generation sequencing workflows using MGI devices and products.

Under the collaboration, Nalagenetics, a genetic testing company with a presence in Singapore and Indonesia, will offer its Clinical Decision Support software to analyze WGS data generated by MGI's DNBSeq sequencing platform to create "clinical-grade reports" for pharmacogenomics and polygenic risk scores, according to MGI.

"Pharmacogenetic testing adoption in Southeast Asia is still low despite interest from customers, as next-generation sequencing is a multi-step process that can be complex and difficult to implement in existing settings," Roy Tan, general manager of MGI Asia Pacific, said in a statement. "The partnership with Nalagenetics will merge both our expertise and bring about a simplified next-generation sequencing workflow with automation, sequencing primer design, and process QC within [the] current healthcare framework."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.